1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
THR B 27 - PRO B 28 MODEL 1 OMEGA = 41.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 3 OMEGA = 214.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 4 OMEGA = 213.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 8 OMEGA = 216.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 10 OMEGA = 241.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 11 OMEGA = 217.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 13 OMEGA = 233.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
CIS PROLINE - PRO B 28 MODEL 15
THR B 27 - PRO B 28 MODEL 19 OMEGA = 240.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
THR B 27 - PRO B 28 MODEL 20 OMEGA = 91.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
Jorgensen, A.M.M.
Kristensen, S.M.
Led, J.J.
Balschmidt, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
227
1146
1163
10.1016/0022-2836(92)90527-Q
1433291
Three-dimensional solution structure of an insulin dimer. A study of the B9(Asp) mutant of human insulin using nuclear magnetic resonance, distance geometry and restrained molecular dynamics.
1992
UK
Magn.Reson.Chem.
MRCHEG
0731
0749-1581
33
461
A Carbon-13 NMR Study of the B9(Asp) Mutant of Human Insulin
1995
US
Biochemistry
BICHAW
0033
0006-2960
33
13727
Structural Details of Asp(B9) Human Insulin at Low Ph from 2D NMR Titration Studies
1994
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
116
747
A New Linear Prediction Model Method for the Determination of Slow Amide Proton Exchange Rates from a Series of One-Dimensional 1H NMR Spectra
1994
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
115
1457
Slow Amide Proton Exchange Rates from the Line Widths in a Single Two-Dimensional 1H NMR Spectrum
1993
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
218
221
Proton Nuclear Magnetic Resonance Study of the B9(Asp) Mutant of Human Insulin. Sequential Assignment and Secondary Structure
1991
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2383.698
INSULIN
S(B 9)D
1
man
polymer
3461.963
INSULIN
S(B 9)D
1
man
polymer
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGDHLVEALYLVCGERGFFYTPKT
FVNQHLCGDHLVEALYLVCGERGFFYTPKT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
baker's yeast
Saccharomyces
sample
9606
Homo sapiens
4932
Saccharomyces cerevisiae
human
Homo
baker's yeast
Saccharomyces
sample
9606
Homo sapiens
4932
Saccharomyces cerevisiae
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1995-10-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1994-11-30
REL
REL
20
HAVEL,WUTHRICH
refinement
DISGEO
BRUNGER
refinement
X-PLOR
2.1
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
ASP
9
n
9
ASP
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
THR
PRO
27
28
41.00
3
B
B
THR
PRO
27
28
-145.94
4
B
B
THR
PRO
27
28
-146.63
8
B
B
THR
PRO
27
28
-143.76
10
B
B
THR
PRO
27
28
-118.97
11
B
B
THR
PRO
27
28
-142.35
13
B
B
THR
PRO
27
28
-126.58
19
B
B
THR
PRO
27
28
-119.15
20
B
B
THR
PRO
27
28
91.63
1
B
ARG
22
0.111
SIDE CHAIN
2
B
ARG
22
0.292
SIDE CHAIN
3
B
ARG
22
0.296
SIDE CHAIN
4
B
ARG
22
0.166
SIDE CHAIN
5
B
ARG
22
0.285
SIDE CHAIN
6
B
ARG
22
0.279
SIDE CHAIN
7
B
ARG
22
0.212
SIDE CHAIN
8
B
ARG
22
0.289
SIDE CHAIN
9
B
ARG
22
0.277
SIDE CHAIN
10
B
ARG
22
0.286
SIDE CHAIN
11
B
ARG
22
0.142
SIDE CHAIN
12
B
ARG
22
0.327
SIDE CHAIN
13
B
ARG
22
0.211
SIDE CHAIN
14
B
ARG
22
0.294
SIDE CHAIN
15
B
ARG
22
0.299
SIDE CHAIN
16
B
ARG
22
0.267
SIDE CHAIN
17
B
ARG
22
0.195
SIDE CHAIN
18
B
ARG
22
0.305
SIDE CHAIN
19
B
ARG
22
0.305
SIDE CHAIN
20
B
ARG
22
0.310
SIDE CHAIN
1
7.19
1.10
114.20
121.39
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
2
7.72
1.10
114.20
121.92
B
B
B
CA
CB
SG
CYS
CYS
CYS
19
19
19
N
2
19.02
2.70
111.00
130.02
B
B
B
N
CA
C
CYS
CYS
CYS
19
19
19
N
3
-8.05
0.50
120.30
112.25
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
N
3
4.43
0.50
120.30
124.73
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
3
-17.23
2.10
128.40
111.17
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
4
8.89
1.10
114.20
123.09
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
4
15.00
2.00
110.40
125.40
B
B
B
CB
CA
C
GLU
GLU
GLU
21
21
21
N
4
-12.41
1.80
110.60
98.19
B
B
B
N
CA
CB
GLU
GLU
GLU
21
21
21
N
4
-17.34
2.20
117.20
99.86
B
B
B
CA
C
N
GLU
GLU
ARG
21
21
22
Y
5
19.25
2.70
111.00
130.25
A
A
A
N
CA
C
SER
SER
SER
12
12
12
N
5
-14.70
2.20
117.20
102.50
B
B
B
CA
C
N
GLU
GLU
ARG
21
21
22
Y
5
-5.16
0.50
120.30
115.14
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
6
6.87
1.10
114.20
121.07
A
A
A
CA
CB
SG
CYS
CYS
CYS
6
6
6
N
6
-14.31
2.30
110.00
95.69
A
A
A
OG1
CB
CG2
THR
THR
THR
8
8
8
N
6
7.35
1.20
111.50
118.85
A
A
A
CB
CA
C
CYS
CYS
CYS
20
20
20
N
6
-10.88
1.80
110.60
99.72
A
A
A
N
CA
CB
CYS
CYS
CYS
20
20
20
N
6
6.93
1.10
114.20
121.13
A
A
A
CA
CB
SG
CYS
CYS
CYS
20
20
20
N
6
-10.99
1.80
110.60
99.61
B
B
B
N
CA
CB
ASP
ASP
ASP
9
9
9
N
6
-5.26
0.50
120.30
115.04
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
7
7.65
1.10
114.20
121.85
B
B
B
CA
CB
SG
CYS
CYS
CYS
19
19
19
N
8
-15.40
2.20
113.40
98.00
A
A
A
CA
CB
CG
GLU
GLU
GLU
17
17
17
N
8
-13.51
2.20
117.20
103.69
B
B
B
CA
C
N
GLU
GLU
ARG
21
21
22
Y
8
17.44
2.70
111.00
128.44
B
B
B
N
CA
C
ARG
ARG
ARG
22
22
22
N
8
-17.13
2.10
128.40
111.27
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
9
7.16
1.10
114.20
121.36
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
10
9.69
1.10
114.20
123.89
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
10
18.22
2.70
111.00
129.22
A
A
A
N
CA
C
SER
SER
SER
12
12
12
N
10
-3.85
0.60
121.00
117.15
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
10
11.28
1.10
114.20
125.48
B
B
B
CA
CB
SG
CYS
CYS
CYS
19
19
19
N
10
17.73
2.70
111.00
128.73
B
B
B
N
CA
C
PHE
PHE
PHE
24
24
24
N
10
-17.24
2.10
128.40
111.16
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
11
23.11
2.70
111.00
134.11
A
A
A
N
CA
C
SER
SER
SER
12
12
12
N
11
-10.49
1.70
113.60
103.11
B
B
B
CA
CB
CG
HIS
HIS
HIS
5
5
5
N
11
-4.95
0.60
121.00
116.05
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
11
3.70
0.60
121.00
124.70
B
B
B
CB
CG
CD1
TYR
TYR
TYR
16
16
16
N
11
-3.70
0.50
120.30
116.60
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
11
17.37
2.70
111.00
128.37
B
B
B
N
CA
C
ARG
ARG
ARG
22
22
22
N
11
-16.09
2.10
128.40
112.31
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
12
6.82
1.10
114.20
121.02
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
12
8.14
1.20
123.30
131.44
A
A
A
OE1
CD
OE2
GLU
GLU
GLU
17
17
17
N
12
-12.87
1.80
110.60
97.73
A
A
A
N
CA
CB
ASN
ASN
ASN
18
18
18
N
12
-3.87
0.60
121.00
117.13
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
12
-3.13
0.50
120.30
117.17
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
N
13
18.66
2.70
111.00
129.66
A
A
A
N
CA
C
ILE
ILE
ILE
10
10
10
N
13
-3.28
0.50
120.30
117.02
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
13
-15.80
2.10
128.40
112.60
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
14
6.96
1.10
114.20
121.16
A
A
A
CA
CB
SG
CYS
CYS
CYS
6
6
6
N
14
-4.09
0.50
120.30
116.21
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
N
14
-18.08
2.10
128.40
110.32
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
15
-16.05
2.30
110.00
93.95
A
A
A
OG1
CB
CG2
THR
THR
THR
8
8
8
N
15
-12.03
1.90
113.40
101.37
A
A
A
CA
CB
CG
TYR
TYR
TYR
19
19
19
N
15
-4.97
0.60
121.00
116.03
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
15
4.41
0.60
121.00
125.41
B
B
B
CB
CG
CD1
TYR
TYR
TYR
16
16
16
N
15
-13.61
1.80
110.60
96.99
B
B
B
N
CA
CB
ARG
ARG
ARG
22
22
22
N
15
-4.00
0.50
120.30
116.30
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
N
15
23.19
2.70
111.00
134.19
B
B
B
N
CA
C
ARG
ARG
ARG
22
22
22
N
15
-13.07
2.00
116.20
103.13
B
B
B
CA
C
N
ARG
ARG
GLY
22
22
23
Y
16
-14.11
2.20
111.50
97.39
A
A
A
N
CA
CB
VAL
VAL
VAL
3
3
3
N
16
-11.57
1.80
110.60
99.03
A
A
A
N
CA
CB
CYS
CYS
CYS
11
11
11
N
16
12.67
1.10
114.20
126.87
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
16
21.94
2.70
111.00
132.94
A
A
A
N
CA
C
SER
SER
SER
12
12
12
N
17
8.71
1.10
114.20
122.91
A
A
A
CA
CB
SG
CYS
CYS
CYS
11
11
11
N
17
19.70
2.70
111.00
130.70
A
A
A
N
CA
C
SER
SER
SER
12
12
12
N
17
-4.54
0.60
121.00
116.46
B
B
B
CB
CG
CD2
TYR
TYR
TYR
16
16
16
N
17
3.66
0.60
121.00
124.66
B
B
B
CB
CG
CD1
TYR
TYR
TYR
16
16
16
N
17
8.55
1.10
114.20
122.75
B
B
B
CA
CB
SG
CYS
CYS
CYS
19
19
19
N
17
-16.14
2.20
117.20
101.06
B
B
B
CA
C
N
GLU
GLU
ARG
21
21
22
Y
17
15.73
2.50
121.70
137.43
B
B
B
C
N
CA
GLU
ARG
ARG
21
22
22
Y
17
-11.79
1.80
110.60
98.81
B
B
B
N
CA
CB
ARG
ARG
ARG
22
22
22
N
17
-4.80
0.50
120.30
115.50
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
22
22
22
N
17
25.27
2.70
111.00
136.27
B
B
B
N
CA
C
ARG
ARG
ARG
22
22
22
N
17
-15.55
2.10
128.40
112.85
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
18
7.84
1.20
111.50
119.34
A
A
A
CB
CA
C
CYS
CYS
CYS
7
7
7
N
18
-12.33
1.80
110.60
98.27
A
A
A
N
CA
CB
CYS
CYS
CYS
7
7
7
N
19
9.31
1.10
114.20
123.51
B
B
B
CA
CB
SG
CYS
CYS
CYS
19
19
19
N
19
-15.30
2.10
128.40
113.10
B
B
B
C
N
CD
THR
PRO
PRO
27
28
28
Y
1
B
B
CZ
NH1
ARG
ARG
22
22
-0.084
0.013
1.326
1.242
N
1
B
B
CZ
NH2
ARG
ARG
22
22
-0.086
0.013
1.326
1.240
N
2
B
B
CZ
NH2
ARG
ARG
22
22
-0.084
0.013
1.326
1.242
N
3
B
B
CG
ND1
HIS
HIS
5
5
-0.093
0.015
1.369
1.276
N
3
B
B
CZ
NH1
ARG
ARG
22
22
-0.093
0.013
1.326
1.233
N
4
B
B
CB
CG
GLU
GLU
21
21
0.161
0.019
1.517
1.678
N
5
B
B
CG
ND1
HIS
HIS
5
5
-0.093
0.015
1.369
1.276
N
5
B
B
CZ
NH1
ARG
ARG
22
22
-0.078
0.013
1.326
1.248
N
5
B
B
CZ
NH2
ARG
ARG
22
22
-0.085
0.013
1.326
1.241
N
6
B
B
CZ
NH2
ARG
ARG
22
22
-0.083
0.013
1.326
1.243
N
9
B
B
CZ
NH1
ARG
ARG
22
22
-0.083
0.013
1.326
1.243
N
9
B
B
CZ
NH2
ARG
ARG
22
22
-0.080
0.013
1.326
1.246
N
10
B
B
CZ
NH1
ARG
ARG
22
22
-0.081
0.013
1.326
1.245
N
10
B
B
CZ
NH2
ARG
ARG
22
22
-0.083
0.013
1.326
1.243
N
11
B
B
CG
ND1
HIS
HIS
5
5
-0.096
0.015
1.369
1.273
N
11
B
B
CZ
NH2
ARG
ARG
22
22
-0.081
0.013
1.326
1.245
N
12
B
B
CZ
NH1
ARG
ARG
22
22
-0.083
0.013
1.326
1.243
N
12
B
B
CZ
NH2
ARG
ARG
22
22
-0.082
0.013
1.326
1.244
N
13
B
B
CZ
NH2
ARG
ARG
22
22
-0.079
0.013
1.326
1.247
N
14
B
B
CZ
NH1
ARG
ARG
22
22
-0.083
0.013
1.326
1.243
N
16
B
B
CZ
NH1
ARG
ARG
22
22
-0.079
0.013
1.326
1.247
N
18
B
B
CZ
NH1
ARG
ARG
22
22
-0.081
0.013
1.326
1.245
N
18
B
B
CZ
NH2
ARG
ARG
22
22
-0.080
0.013
1.326
1.246
N
19
B
B
CZ
NH1
ARG
ARG
22
22
-0.084
0.013
1.326
1.242
N
20
B
B
CZ
NH1
ARG
ARG
22
22
-0.085
0.013
1.326
1.241
N
20
B
B
CZ
NH2
ARG
ARG
22
22
-0.086
0.013
1.326
1.240
N
1
A
VAL
3
-24.82
-98.35
1
A
GLU
4
-71.54
33.86
1
A
GLN
5
-138.40
-40.41
1
A
CYS
7
-107.14
-64.46
1
A
THR
8
-99.57
58.69
1
A
SER
9
146.65
-175.84
1
A
CYS
11
-150.78
3.54
1
A
LEU
13
105.72
-52.55
1
A
LEU
16
-18.99
-52.08
1
A
ASN
18
-37.01
-21.54
1
B
VAL
2
-42.04
62.13
1
B
ASN
3
-58.50
23.25
1
B
GLN
4
-119.02
-132.47
1
B
PHE
24
96.63
61.35
1
B
TYR
26
-73.65
46.62
1
B
PRO
28
4.56
53.79
2
A
ILE
2
45.05
-71.12
2
A
VAL
3
-50.63
-77.05
2
A
GLN
5
119.92
-46.47
2
A
THR
8
-110.01
-88.19
2
A
ILE
10
1.64
131.25
2
A
CYS
11
-117.12
-157.20
2
A
ASN
18
-35.27
-34.93
2
B
ASN
3
-142.44
-84.00
2
B
GLN
4
115.26
162.60
2
B
HIS
5
-34.54
71.40
2
B
CYS
19
-5.90
29.93
2
B
ARG
22
-28.13
87.81
2
B
PHE
24
117.30
76.96
2
B
PRO
28
-19.00
-64.72
2
B
LYS
29
27.84
78.68
3
A
ILE
2
11.34
21.52
3
A
VAL
3
-88.17
-120.55
3
A
GLU
4
-65.64
71.08
3
A
GLN
5
-175.93
-38.10
3
A
THR
8
143.97
98.53
3
A
SER
9
114.27
-162.77
3
A
CYS
11
-57.59
91.03
3
A
SER
12
-37.49
174.27
3
B
GLN
4
-6.83
61.98
3
B
HIS
5
-109.38
66.18
3
B
CYS
7
-112.25
70.63
3
B
LEU
15
-83.72
31.39
3
B
TYR
16
-123.52
-51.26
3
B
ARG
22
-100.89
-164.96
3
B
PHE
24
64.50
96.64
3
B
THR
27
134.87
-66.55
3
B
PRO
28
7.99
46.31
3
B
LYS
29
-134.45
-46.14
4
A
ILE
2
71.92
-68.04
4
A
VAL
3
-4.96
-112.93
4
A
GLU
4
-55.27
11.60
4
A
THR
8
-134.42
-44.29
4
A
SER
9
-108.85
-137.28
4
A
SER
12
-109.61
-135.30
4
A
LEU
13
-21.45
-55.71
4
A
GLN
15
-93.28
30.77
4
A
ASN
18
-43.98
-17.87
4
B
ASN
3
-131.70
-41.02
4
B
GLN
4
42.45
-58.53
4
B
CYS
19
-8.06
62.30
4
B
GLU
21
61.27
75.08
4
B
ARG
22
-15.92
72.68
4
B
TYR
26
17.72
-70.02
4
B
THR
27
16.37
-101.39
4
B
PRO
28
1.27
64.94
5
A
ILE
2
59.79
-39.57
5
A
VAL
3
-85.55
-85.23
5
A
THR
8
-143.21
-48.76
5
A
SER
9
-120.20
-156.38
5
A
SER
12
-29.10
75.30
5
A
LEU
13
86.02
-51.20
5
A
LEU
16
-130.48
-48.89
5
A
ASN
18
-35.17
-37.32
5
B
VAL
2
-52.46
75.29
5
B
GLN
4
93.52
172.55
5
B
HIS
5
-120.07
-164.71
5
B
LEU
15
-58.34
-4.12
5
B
GLU
21
22.11
51.50
5
B
ARG
22
-78.67
-162.23
5
B
PHE
24
122.10
63.78
5
B
TYR
26
-41.67
-169.71
5
B
THR
27
30.54
154.84
5
B
PRO
28
-22.19
-36.54
5
B
LYS
29
16.54
-50.05
6
A
ILE
2
72.90
-69.32
6
A
VAL
3
-5.74
-126.19
6
A
GLU
4
-21.70
-62.83
6
A
SER
9
-122.23
-153.55
6
A
CYS
11
-131.85
-156.55
6
A
ASN
18
-39.21
-23.39
6
B
VAL
2
-120.55
-163.50
6
B
ASN
3
-52.65
82.48
6
B
HIS
5
-119.59
51.88
6
B
CYS
7
-134.53
-53.51
6
B
LEU
11
163.81
-63.24
6
B
TYR
26
3.83
-75.12
6
B
THR
27
85.95
-81.40
6
B
PRO
28
8.70
67.43
7
A
ILE
2
144.12
-46.90
7
A
VAL
3
-45.59
-70.88
7
A
THR
8
-156.66
-52.49
7
A
SER
9
-108.69
-148.28
7
A
CYS
20
-98.81
-128.01
7
B
HIS
5
-44.48
65.71
7
B
CYS
19
-9.66
60.50
7
B
ARG
22
-26.26
50.94
7
B
PHE
24
13.77
103.03
7
B
TYR
26
-2.64
59.75
7
B
PRO
28
-7.19
84.32
7
B
LYS
29
-118.25
61.73
8
A
VAL
3
-2.78
-111.50
8
A
THR
8
-109.43
-75.70
8
A
ILE
10
-1.09
103.08
8
A
SER
12
-43.29
158.81
8
A
ASN
18
-35.10
-28.19
8
B
VAL
2
-50.52
70.05
8
B
GLN
4
-128.82
-131.85
8
B
CYS
19
-3.70
49.57
8
B
ARG
22
-28.18
75.71
8
B
PHE
25
-51.08
69.99
8
B
TYR
26
-69.44
58.78
8
B
PRO
28
17.58
68.48
9
A
VAL
3
-23.82
-78.76
9
A
GLU
4
-72.93
20.50
9
A
GLN
5
-120.00
-61.12
9
A
THR
8
-154.41
-60.37
9
A
ILE
10
8.41
97.04
9
A
GLU
17
-68.53
6.59
9
A
CYS
20
-66.44
87.12
9
B
ASN
3
-123.54
-53.01
9
B
GLN
4
49.65
-65.56
9
B
GLU
13
-57.53
2.52
9
B
LEU
15
-26.00
-65.96
9
B
TYR
16
-38.49
-38.12
9
B
VAL
18
-35.11
-78.48
9
B
GLU
21
71.22
71.63
9
B
PHE
24
-6.30
105.11
9
B
PHE
25
-66.85
69.12
9
B
PRO
28
-76.65
23.67
9
B
LYS
29
-12.09
54.23
10
A
ILE
2
127.51
-60.74
10
A
GLU
4
-55.24
2.18
10
A
THR
8
-152.06
-61.65
10
A
SER
9
-106.91
74.03
10
A
ILE
10
3.02
78.38
10
A
LEU
13
126.87
-65.97
10
A
ASN
18
-35.51
-26.33
10
B
ASN
3
125.56
-32.93
10
B
GLN
4
30.59
37.91
10
B
CYS
7
-109.04
-62.98
10
B
HIS
10
-42.21
-19.27
10
B
CYS
19
-78.65
23.90
10
B
GLU
21
-131.54
-58.95
10
B
PHE
24
85.67
108.38
10
B
TYR
26
-0.40
131.50
10
B
THR
27
-24.49
-90.29
10
B
PRO
28
25.50
-55.73
10
B
LYS
29
-14.89
-45.82
11
A
ILE
2
40.98
-72.41
11
A
VAL
3
-33.26
-71.90
11
A
THR
8
-139.27
-46.29
11
A
SER
9
-114.02
-148.97
11
A
SER
12
-40.20
54.91
11
A
LEU
13
83.65
-49.04
11
A
LEU
16
-126.26
-53.36
11
A
ASN
18
-39.40
-29.92
11
A
CYS
20
-98.54
44.51
11
B
VAL
2
-90.47
-156.49
11
B
ASN
3
99.88
52.44
11
B
GLN
4
-59.91
86.70
11
B
HIS
5
-42.04
170.83
11
B
CYS
19
-42.78
67.25
11
B
ARG
22
-31.03
166.58
11
B
PHE
24
96.61
142.33
11
B
PHE
25
-107.06
44.17
11
B
TYR
26
-59.77
96.66
11
B
PRO
28
1.61
-58.85
11
B
LYS
29
-3.14
63.57
12
A
ILE
2
-26.73
-63.17
12
A
VAL
3
-36.00
-101.77
12
A
GLU
4
-29.52
-21.88
12
A
ILE
10
6.72
120.20
12
A
ASN
18
-39.40
-28.34
12
B
ASN
3
26.93
82.07
12
B
GLN
4
-125.01
-156.00
12
B
HIS
5
-108.11
77.43
12
B
ALA
14
-93.04
-60.55
12
B
PHE
24
7.93
156.43
12
B
TYR
26
-41.93
81.16
12
B
PRO
28
-16.16
-56.27
12
B
LYS
29
-2.21
89.92
13
A
GLU
4
30.16
-109.62
13
A
GLN
5
-24.52
-30.64
13
A
SER
9
9.50
37.08
13
A
ILE
10
-8.84
147.23
13
A
CYS
11
-127.89
-166.69
13
B
ASN
3
84.42
-33.62
13
B
GLN
4
-23.76
56.76
13
B
HIS
5
-66.61
72.61
13
B
PHE
24
-4.29
104.69
13
B
THR
27
-111.86
-95.37
13
B
PRO
28
2.24
53.17
14
A
THR
8
-157.28
-48.10
14
A
SER
9
-108.57
-128.14
14
A
ILE
10
-130.17
-59.35
14
A
CYS
11
56.31
128.71
14
A
ASN
18
-39.55
-31.02
14
B
ASN
3
-38.17
69.28
14
B
PHE
24
157.72
154.32
14
B
PHE
25
-115.56
71.37
14
B
PRO
28
-105.72
40.04
14
B
LYS
29
-3.19
52.93
15
A
SER
9
-112.31
-148.62
15
A
CYS
20
-58.89
16.22
15
B
VAL
2
-105.28
-151.62
15
B
ASN
3
110.94
49.30
15
B
GLN
4
-158.33
-151.63
15
B
CYS
7
-129.70
-56.51
15
B
HIS
10
-48.17
-12.03
15
B
GLU
13
-37.03
-34.28
15
B
TYR
16
-27.16
-52.25
15
B
CYS
19
-38.59
63.61
15
B
GLU
21
38.81
36.78
15
B
PHE
24
119.31
77.72
15
B
PRO
28
15.10
56.26
16
A
ILE
2
78.20
-64.34
16
A
VAL
3
-26.17
162.19
16
A
GLU
4
43.15
-7.30
16
A
GLN
5
-127.19
-52.53
16
A
CYS
7
-136.66
-30.10
16
A
THR
8
-134.15
-62.33
16
A
ILE
10
2.22
84.79
16
A
LEU
13
110.79
-56.02
16
A
ASN
18
-36.39
-33.47
16
A
CYS
20
-112.50
67.20
16
B
VAL
2
-37.28
78.21
16
B
ASN
3
-5.44
49.77
16
B
GLN
4
2.13
-50.29
16
B
CYS
7
19.44
164.51
16
B
CYS
19
-129.39
-135.90
16
B
GLU
21
-76.86
27.62
16
B
ARG
22
-62.60
25.27
16
B
PHE
24
41.22
72.12
16
B
PHE
25
-52.88
73.89
16
B
THR
27
7.88
95.32
16
B
PRO
28
-97.42
50.11
17
A
VAL
3
-4.26
-126.27
17
A
GLU
4
-27.56
-72.84
17
A
SER
9
-120.14
-161.42
17
A
SER
12
-44.33
90.12
17
A
LEU
13
116.62
-43.94
17
B
VAL
2
-119.95
64.63
17
B
HIS
5
-110.19
68.58
17
B
TYR
16
-27.80
-44.27
17
B
CYS
19
-42.64
67.77
17
B
ARG
22
-24.50
63.98
17
B
PHE
24
11.46
77.06
17
B
THR
27
-96.60
48.96
17
B
PRO
28
4.33
38.64
18
A
ILE
2
-131.47
-59.51
18
A
GLU
4
-107.43
-78.93
18
A
GLN
5
-46.97
-18.74
18
A
THR
8
173.30
48.39
18
A
SER
9
140.36
-160.55
18
A
SER
12
-109.49
-160.85
18
A
CYS
20
-112.12
69.97
18
B
GLN
4
5.44
-89.40
18
B
CYS
7
-128.32
-55.56
18
B
LEU
11
168.42
-59.22
18
B
PHE
24
10.12
166.80
18
B
THR
27
-11.16
-118.93
18
B
LYS
29
-131.63
-47.93
19
A
ILE
2
103.49
145.78
19
A
VAL
3
28.66
-150.09
19
A
GLU
4
-65.35
19.06
19
A
CYS
7
-114.91
51.71
19
A
THR
8
136.26
62.00
19
A
SER
9
138.61
-170.52
19
B
ASN
3
-3.34
-58.36
19
B
GLN
4
104.00
-104.35
19
B
HIS
5
-117.31
71.66
19
B
HIS
10
-59.72
1.96
19
B
GLU
21
84.55
0.78
19
B
ARG
22
-108.36
-127.26
19
B
PHE
24
-68.83
66.19
19
B
PHE
25
-92.07
56.49
19
B
TYR
26
-21.65
-20.06
19
B
THR
27
-12.73
-71.32
19
B
PRO
28
23.74
-69.14
19
B
LYS
29
0.47
-51.54
20
A
ILE
2
-0.53
48.21
20
A
VAL
3
-38.20
-114.24
20
A
GLN
5
170.38
-49.61
20
A
SER
9
110.49
38.66
20
A
ILE
10
-3.79
105.89
20
A
SER
12
-41.16
176.50
20
A
CYS
20
-118.37
79.59
20
B
ASN
3
176.63
-37.79
20
B
GLN
4
-115.69
-146.68
20
B
LEU
17
-123.02
-53.41
20
B
VAL
18
-52.34
-71.29
20
B
CYS
19
-26.03
-63.37
20
B
ARG
22
-124.71
-90.05
20
B
PHE
24
61.31
69.61
20
B
TYR
26
36.51
114.14
20
B
PRO
28
-9.56
58.93
20
B
LYS
29
135.28
-20.10
INSULIN
THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN INSULIN USING NUCLEAR MAGNETIC RESONANCE DISTANCE GEOMETRY AND RESTRAINED MOLECULAR DYNAMICS
1
N
N
2
N
N
A
ILE
2
A
ILE
2
HELX_P
ALPHA HELIX
A
THR
8
A
THR
8
1
A1
7
A
LEU
13
A
LEU
13
HELX_P
ALPHA HELIX
A
CYS
20
A
CYS
20
1
A2
8
B
GLY
8
B
GLY
8
HELX_P
ALPHA HELIX
B
CYS
19
B
CYS
19
1
B1
12
disulf
1.930
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.141
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
1.976
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE
HORMONE
B
THR
27
B
THR
27
15
B
PRO
28
B
PRO
28
23.98
INS_HUMAN
UNP
1
90
P01308
INS_HUMAN
UNP
2
25
P01308
90
110
1MHI
1
21
P01308
A
1
1
21
25
54
1MHI
1
30
P01308
B
2
1
30
2
SER
CONFLICT
ASP
9
1MHI
B
P01308
UNP
33
9
1
P 1